These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 19685467)

  • 41. Enabling Europe to innovate.
    Dearing A
    Science; 2007 Jan; 315(5810):344-7. PubMed ID: 17234939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Marketplace. U.S. health care exports threatened, warns report asking for policy changes.
    Moskowitz DB
    Med Health; 1998 Sep; 52(38):suppl 1-2. PubMed ID: 10185355
    [No Abstract]   [Full Text] [Related]  

  • 43. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kiran Mazumdar-Shaw.
    Jayaraman KS
    Nat Biotechnol; 2005 Jan; 23(1):11. PubMed ID: 15637602
    [No Abstract]   [Full Text] [Related]  

  • 45. The shape of European business in 2003.
    Wagner M
    Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520
    [No Abstract]   [Full Text] [Related]  

  • 46. Agricultural biotechnology and its contribution to the global knowledge economy.
    Aerni P
    Adv Biochem Eng Biotechnol; 2007; 107():69-96. PubMed ID: 17522821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Public biotech 2006 - the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract]   [Full Text] [Related]  

  • 48. Delisting threat looms large on biotech front.
    Lawrence S
    Nat Biotechnol; 2005 Jan; 23(1):5. PubMed ID: 15637598
    [No Abstract]   [Full Text] [Related]  

  • 49. Do biomaterials really mean business?
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):851-3. PubMed ID: 18688229
    [No Abstract]   [Full Text] [Related]  

  • 50. BIO '06 visible from space?
    Nat Biotechnol; 2006 May; 24(5):474. PubMed ID: 16680109
    [No Abstract]   [Full Text] [Related]  

  • 51. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.
    Caulfield T; Ogbogu U
    Account Res; 2008; 15(4):303-20. PubMed ID: 18972268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gold in the ivory tower: equity rewards of outlicensing.
    Edwards M; Murray F; Yu R
    Nat Biotechnol; 2006 May; 24(5):509-15. PubMed ID: 16680129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Industrial health research in Canada.
    Morin Y
    CMAJ; 2007 Jun; 176(12):1734; author reply 1734. PubMed ID: 17548390
    [No Abstract]   [Full Text] [Related]  

  • 54. Basic and applied research in India: present and future.
    Ramasami T; Rao AV; Natesh S
    Biotechnol J; 2009 Mar; 4(3):301-5. PubMed ID: 19296436
    [No Abstract]   [Full Text] [Related]  

  • 55. The number on biotech indexes.
    Jacobs T
    Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
    [No Abstract]   [Full Text] [Related]  

  • 56. Globalization of biotechnology and the public health challenges accompanying it.
    Malinowski MJ
    Albany Law Rev; 1996; 60(1):119-69. PubMed ID: 10170488
    [No Abstract]   [Full Text] [Related]  

  • 57. Public biotechnology 2003-the numbers.
    Lähteenmäki R; Baker M
    Nat Biotechnol; 2004 Jun; 22(6):665-70. PubMed ID: 15175683
    [No Abstract]   [Full Text] [Related]  

  • 58. Good faith gone bad.
    Bialy H
    Nat Biotechnol; 2000 Nov; 18(11):1123. PubMed ID: 11062389
    [No Abstract]   [Full Text] [Related]  

  • 59. Good faith gone bad-gone good again.
    Bialy H
    Nat Biotechnol; 2005 Jan; 23(1):17. PubMed ID: 15637605
    [No Abstract]   [Full Text] [Related]  

  • 60. Health economics in technology development: is it worth it?
    Lee D
    J Nucl Med; 2008 Jun; 49(6):48N-50N. PubMed ID: 18511826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.